BRIEF-Seres Therapeutics FY EPS USD 0

Reuters
13 Mar
BRIEF-Seres <a href="https://laohu8.com/S/LENZ">Therapeutics</a> FY EPS USD 0

Mar 13 (Reuters) - Seres Therapeutics FY operating expenses USD 121.315 million.

  • FY operating income USD -121.315 million
  • FY net income USD 136 thousand

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10